CASP3 and colorectal cancer: As suggested earlier, knockout/knockdown of caspase-3 in human colorectal cancer cells increased their sensitivity to DNA-damaging agents, such as 5-fluorouracil (5-FU), camptothecin, and etoposide in vivo and in vitro.